Substance Abuse - Level 1/2/3 Flashcards

1
Q

How much paracetamol risks severe liver damage?

A
  • Causes severe liver damage if >12 tablets/150mg per kg taken
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When to admit paracetamol overdose to hospital?

A

o If >75mg/kg in less than 1 hour – admit to hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathology of paracetamol overdose?

A

o Metabolised by CYP450 enzymes to toxic N-acetyl-p-benzoquinone imine (NAPQI) which is conjugated with glutathione before elimination
o NAPQI accumulation causes hepatocellular necrosis
o Renal failure results from acute tubular necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors of paracetamol overdose?

A
o	Alcoholics
o	Drugs which induce hepatic enzymes (St John’s Wort, anticonvulsants, rifampicin)
o	Malnutrition
o	Anorexia
o	Cachexia
o	HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptoms and signs of paracetamol overdose?

A

o Nausea and vomiting, abdominal discomfort

o	Untreated patients:
	Vomiting continues beyond 12 hours
	Pain and tenderness over liver (from 24 hours)
	Jaundice (at 2-4 days)
	Sometimes coma from hypoglycaemia

o Renal Failure
 Loin pain, haematuria, proteinuria

o Hepatic Failure
 Bleeding
 Hyperventilation (metabolic acidosis)
 DIC, cerebral oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Investigations of paracetamol overdose?

A
o	Bloods - Paracetamol levels, FBC, U&Es, LFTs, INR, glucose 
o	ABG (if appropriate)
o	ECG (if appropriate)
o	TOXBASE used for managing drug overdose
  • LFTs normal until >18h after overdose
  • Prolonged INR (from 24h after overdose)
  • ALT and AST raised after 3-4 days
  • Bilirubin rises over 5 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initial management of paracetamol overdose?

A

o ABC, clear airway
 Simple airway manoeuvres
 Oropharyngeal or nasopharyngeal airway if reduced consciousness
 Consider ventilation

o Activated Charcoal 1g/kg (max 50g)
 If <1h after OD, ingestion >150mg/kg paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Investigations to performed in paracetamol overdose?

A

o Bloods – FBC, U&E, LFT, INR, HCO3, ABG

o Blood paracetamol levels at 4h post-ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Further management of paracetamol overdose - what?

A

 IV Acetylcysteine (Parvolex) of 3 consecuative infusions over total of 21 hours
• IVI 150mg/kg in 200ml 5% dextrose over 1h
• IVI 50mg/kg in 500ml of 5% dextrose over 4h
• IVI 100mg/kg in 1L of 5% dextrose over 16h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Further management of paracetamol overdose - when?

A
  • If over-line of treatment
  • Presentation of 8-24h after overdose of >150mg/kg
  • If over 24 hours, give Acetylcysteine immediately and seek expert help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Further management of paracetamol overdose - if ingestion time unknown, staggered (first dose to last >1 hour) or presentation 8-24 hours from ingestion of >150mg/kg?

A

Get senior advice

Start Acetylcysteine immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When can you discharge patient with paracetamol overdose?

A

After treatment course of Acetylcysteine and asymptomatic with normal LFTs, serum creatinine and INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis of paracetamol overdose?

A
  • Treatment within 8h of ingestion is very effective in preventing liver and renal damage
  • Later treatment less effective but worthwhile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Names of opiates?

A

morphine, diamorphine (heroin), pethidine, codeine, buprenorphine, methadone, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of opiates?

A

Opioid agonist, binds to endorphin receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effects of opiates?

A

o Warm feeling, euphoria, relaxed, analgesic, constricted (pin-point) pupils, untethering from worries or concerns
o Opiate dependency develops in weeks and associated with withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Poisoning symptoms of opiates?

A
o	Coma
o	Respiratory depression
	Usually within 1h causes death
	Methadone is long-acting so can be delayed over 24-48h
o	Pinpoint pupils
o	Cyanosis, apnoeas
o	Convulsions
o	Hypotension
o	Non-cardiogenic pulmonary oedema – from ‘main-lining’ heroin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Investigations of opiate overdose?

A
o	Bloods
	Paracetamol levels
	FBC, U&amp;Es, LFTs, INR, glucose 
o	ABG (if appropriate)
o	ECG (if appropriate)
o	TOXBASE used for managing drug overdose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Initial management of opiate overdose?

A

o Maintain airway

o Ventilate with O2 in bag and mask or ET tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of opiate overdose if patient rousable, not cyanosed and RR>8?

A

o If patient easily rousable, not cyanosed and RR>8 – observe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Management of opiate overdose if coma, bradypnoea (RR<8)?

A

 Naloxone if coma or bradypnoea (<8breath/min) and monitor for response
 400mcg IV, then 800mcg for up to 2 doses at 1 minute intervals, then up to 2mg for 1 dose then review diagnosis
 In drug addicts – naloxone precipitates feature of opiate withdrawal
• Diarrhoea and cramps – settle or responds to Lomotil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Further management of opiate overdose?

A

o Sedate as needed
o Observation for 6 hours after last naloxone dose
o Register opiate addiction and refer for help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Severity of aspirin overdose?

A

o 150mg/kg – Mild
o 250mg/kg – Moderate
o >500mg/kg - Severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Early features of aspirin overdose?

A

o Vomiting, dehydration, hyperventilation, tinnitus & deafness, vertigo, sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Other features of aspirin overdose?

A

o Low GCS, seizures, low BP, heart block and pulmonary oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

General management of aspirin overdose?

A

o Consult TOXBASE
o Fluids if low BP
o ECG monitoring - Sinus tachycardia, prolonged QT, dysrhythmias
o Activated charcoal if present within 1 hour if >125mg/kg of aspirin ingested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Investigations of aspirin overdose?

A
  • Bloods
    o Paracetamol levels
    o Salicylate levels – repeat at 2 hours if large overdose until peak
    o FBC, U&E, (AKI, low K, Ca, Mg), LFT, glucose, INR
    o ABG:
     Initially respiratory alkalosis due to stimulation of CNS respiratory system but then develop metabolic acidosis
  • Urine
    o Catheter, measure pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Management of aspirin overdose?

A
  • Correct acidosis
    o If plasma salicylate >500mg/L – alkalinisation of urine with sodium bicarbonate IV over 3 hours
    o Aim for urine pH 7.5-8.5
  • Dialysis
    o If late features, levels >700mg/L or severe metabolic acidosis
29
Q

Current guidelines for alcohol ingestion?

A
  • Current guidelines suggest men and women don’t regularly exceed 14 units per week, spread over 3 days
30
Q

Definition of harmful drinking?

A
  • Harmful drinking is defined as a pattern of alcohol consumption causing health problems directly related to alcohol
31
Q

Criteria for alcohol dependence?

A
o	Craving
o	Tolerance
o	Withdrawal: sweats, nausea, tremor
o	Preoccupation with alcohol and continued drinking despite harmful consequences
o	Prioritise drink
o	Tried to stop? Failed?
32
Q

Epidemiology of alcohol dependence?

A
  • Alcohol dependence affects 1 in 20 people in UK

- Men 2:1 Women

33
Q

Physiology of alcohol?

A

o Alcohol enhances GABAergic transmission (anxiolytic effects), releases dopamine in mesolimbic system (euphoriant effects) and inhibits NMDA transmission (amnesic effects)

34
Q

Risk factors of alcohol dependence?

A
o	Men, lower socioeconomic class, young
o	Family history of dependence
o	Bereavement
o	Unemployment
o	Job area
o	Price
35
Q

Symptoms of alcohol intoxification?

A

o Elevated mood
o Socialisation
o Disinhibition

36
Q

Withdrawal signs of alcohol dependence?

A

o Agitation
o Tremor
o Nausea
o Sweating

37
Q

Symptoms of delirium tremens?

A
o	Increased pulse
o	Decreased BP
o	Tremor
o	Fits
o	Visual or tactile hallucinations (insect crawling on skin)
38
Q

Mechanism of Wernicke-Korsakoff syndrome?

A
  • Neuronal degeneration secondary to thiamine (B1) deficiency
  • Alcoholism decreased thiamine intake, absorption from GI tract and utilisation in cells
39
Q

Symptoms of Wernicke encephalopathy?

A
•	Acute onset triad
-	Confusional state
-	Opthalmoplegia, nystagmus
-	Wide-based gait ataxia
•	Memory disturbance, hypotension, peripheral neuropathy, hypothermia
40
Q

Symptoms of Korsakoff’s syndrome?

A
  • Hypothalamic damage and cerebral atrophy due to thiamine deficiency
  • Poor laying down of new memories, confabulation
  • Lock of insight
  • Features of Wernicke’s encephalopathy
41
Q

Screening assessment of alcohol dependence?

A

o CAGE questionnaire
• Have you ever felt you should cut down on your drinking?
• Has anyone ever annoyed you by criticising your drinking?
• Have you ever felt guilty about your drinking?
• Have you ever had a drink early in the morning as an eye-opener?
• If 2 or more then ask:
- What is most alcohol you’ve drank in single day and week?

o AUDIT questionnaire

42
Q

Investigations in alcohol dependence?

A

o Blood alcohol concentration
o Blood
• FBC, LFTs, etc
• Elevated ALP, MCV, yGT and CDT markers for excess alcohol consumption

43
Q

Management of alcohol dependence - general advice?

A

o Drinking advice
• Men and women recommended 14 units or less per week
• >2 alcohol free days per week
• Spread over several days
• Do not drink alone
• Pace drinking
• Alternate soft drinks or drink with meal
• Plan alternative activities to replace drinking periods

o If deficient in thiamine then consider thiamine

44
Q

Management of alcohol dependence - if hospital admission and abstinent?

A

• Immediate drug therapy in hospital:

  • For 1st 3 days give chlordiazepoxide PO/PR/IVI
  • Decrease dose after few days and convert to PO
45
Q

Management of alcohol dependence - aiming for abstinence - psychological therapy?

A
o	Psychotherapy (FORWARD Leeds)
•	Motivational interviewing
-	Aimed to move person through stages of change
•	Self-help/Group therapy (AA)
•	CBT
•	Counselling
46
Q

Management of alcohol dependence - aiming for abstinence - pharmacological management?

A

Disulfiram
Naltrexone
Acamprosate

47
Q

Mechanism of disulfiram in alcohol dependence?

A

Produces nasty reaction if alcohol taken)

a. Irreversible inhibition of acetaldehyde dehydrogenase (ALDH) which converts alcohol into water and carbon dioxide
b. Build-up of ALDH causing flushing, headache, nausea, vomiting and tachycardia
c. Prescribe once abstinent
d. SE: Halitosis, headache

48
Q

Mechanism of naltrexone in alcohol dependence?

A

Opioid receptor antagonist, reduces pleasure it gives)

a. Antagonises endogenous endorphins released by alcohol consumption
b. Must be given once abstinent
c. SE: GI upset, anxious, headache, fatigue

49
Q

Mechanism of acamprosate in alcohol dependence?

A

a. Enhances GABA transmission to reduce cravings
b. Once abstinent
c. SE: GI upset, pruritis, rash, altered libido

50
Q

Management of delirium tremens?

A

o Admit and monitor vital signs
o For 1st 3 days give chlordiazepoxide/diazepam PO/PR/IVI
o Decrease dose after few days and convert to PO

51
Q

Management of Wernicke’s Korsakoffs syndrome?

A

o High dose IV/IM thiamine (Pabrinex – B1, 2, 6, 12, C) over 1 week and then oral for a long period – 2 years for Korsakoff’s syndrome
o ¼ of Korsakoff’s reversible but ¼ need long-term institutional care

52
Q

Driving issues - with alcohol misuse?

A

• Loss of licence until 6-months (group 1) or 1-year (group 2) period of abstinence or controlled drinking achieved

53
Q

Driving issues - with alcohol depedence?

A
  • Loss of licence until 1-year (group 1) or 3-year (group 2) period of abstinence with normalisation of blood parameters
  • Consultant support may be required
54
Q

Complications of alcohol dependence?

A
o	Fatty liver, hepatitis, cirrhosis
o	Poor memory, cortical atrophy
o	Arrhythmias, high BP, cardiomyopathy
o	Osteoporosis
o	Decreased fertility
o	Malignancy
o	Crime and Suicide
o	Wernicke’s Korsakoff syndrome
55
Q

Investigations in uncomplicated alcohol withdrawal in hospital?

A

 Bloods
• FBC, LFTs, etc, B1, folate, B12
o Elevated ALP, MCV, yGT and CDT markers for excess alcohol consumption
 BP and TPR every 4 hours

56
Q

Management in uncomplicated alcohol withdrawal in hospital?

A
o	Chlordiazepoxide (10-50mg QDS PO and PRN for 2 days), wean over 7-10 days
	Alternative: Diazepam 5-10mg PO
o	Lorazepam if seizures
o	CIWA-Ar used to guide treatment
o	Thiamine (Pabrinex) if indicated
57
Q

Epidemiology of cigarette smoking?

A
  • Smoking prevalence around 15%
  • Higher in Irish, Pakistani, Bangladeshi
  • Related to deprivation
  • 2/3 who smoke say they want to quit
58
Q

Harms of smoking?

A

o Main cause of premature death and preventable illness in UK
o 50% chance of dying early (10 years average)
o After 35, person loses 3 months of life expectancy for every year smoked

59
Q

Effects of stopping smoking?

A
  • Within 20 mins – pulse normal
  • Within 8 hours – oxygen levels normal, circulation improves
  • Within 24 hours – nicotine eliminated
  • Within 48 hours – sense of taste and smell improve
  • Within 72 hours – breathing easier
  • With months – coughing, appearance improve
60
Q

Withdrawal symptoms of smoking?

A

o Usually temporary and caused by adaptation to long-term smoking
o Weight gain
• Presents a minor health risk compared to risk of smoking
• Often progressive for number of years and average ex-smoker gain 5-9kg if not effort for healthy diet made

  • Lasting <48h - Light-headedness
  • Lasting <1 week - Disturbed sleep
  • Lasting <2 weeks - Poor concentration
  • Lasting <4 weeks -Irritability, aggression, depression, restlessness, nicotine cravings
  • Lasting >10 weeks - Increased appetite
61
Q

Management of someone wanting to stop smoking?

A

o Refer to local smoking cessation service

• Offers behavioural support (individual or group), advice for treatments, supply medications needed

62
Q

Practical advice given to people wanting to stop smoking?

A

• Best way to stop is combination of behavioural support and medication
• Set a date and commit
• Usually improves after 3rd or 4th day
• Cravings set off by stress, seeing others smoke or alcohol
- Manage cravings by: exercise, talking to friends, keep busy
• One puff almost always leads to going back to smoking regularly

63
Q

Drug treatments in smoking cessation programmes - NRT?

A
  • Available as patches (16h and 24h) and fast-acting lozenge or spray PRN
  • Start on quit date
  • To last person until 2 weeks after stop date
64
Q

Drug treatments in smoking cessation programmes - varenicline?

A
  • Partial nicotinic receptor agonist
  • Alleviates cravings and withdrawal and reduces reward
  • Start 7-14 days before quit date and for 12 weeks
65
Q

Drug treatments in smoking cessation programmes - bupropion?

A
  • Weak but selective dopamine and noradrenaline re-uptake inhibitor
  • Start 7-14 days before quite date and for 7-9 weeks
66
Q

Follow up in someone who has stopped smoking?

A
  • 2 weeks in NRT
  • 3-4 weeks in varenicline or bupropion
  • Measure CO level 4 weeks after - <10ppm is non-smoker
67
Q

When can’t you prescribe varenicline or bupropion?

A

Pregnant
Breastfeeding
Children<18

68
Q

Risk factors for ilicit drug use?

A
o	Young age, male gender
o	Low socioeconomic class
o	Psychiatric disorders
o	Impulsive personality
o	Genetic